Skip to content
Medical Health Aged Care

Siloam Hospitals Group and Philips sign AI capability MoU to support Indonesia’s healthcare transformation strategy

Royal Philips 4 mins read

October 7, 2024

Jakarta, Indonesia and Amsterdam, the Netherlands –Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Siloam Hospitals Group, Indonesia’s leading private healthcare provider, have signed a Memorandum of Understanding (MoU) to advance AI capabilities and development in the healthcare sector in Indonesia.

The strategic collaboration, in partnership with the Universitas Pelita Harapan (UPH) Medical Sciences Group, will focus on capacity building, knowledge sharing, and implementing advanced AI solutions. Leveraging Philips’ AI innovations, the collaboration will help transform clinical care and digital health, enhance healthcare delivery and make the healthcare infrastructure more sustainable. The goal is to deliver better care for more people in Indonesia.

This partnership aligns with the Indonesian government’s healthcare strategy to improve healthcare accessibility, enhance clinical outcomes, and embrace digital transformation.

Key areas of focus in the partnership:

1. AI-driven clinical care: Philips intends to introduce its cutting-edge AI technologies into Siloam Hospitals, particularly in areas such as radiology, pathology, (interventional) cardiology and clinical operations. AI will enhance clinical decision-making and improve workflows, enabling healthcare professionals to diagnose and treat patients with greater precision and to enhance capacity of the system to be able support more patients.

2. Capacity building and local AI expertise: The MoU will focus on the development of local expertise in AI and digital health through collaboration with the UPH Medical Sciences Group. This initiative includes training programs to enable healthcare professionals, IT specialists and UPH students with the necessary skills to develop and apply AI in clinical settings.

3. Global knowledge sharing with Philips: As a global leader in informatics and AI for healthcare, Philips will share its expertise and global best practices with Siloam Hospitals and UPH. The collaboration includes aligning with Philips’ informatics, AI research and global healthcare strategies to create scalable solutions tailored to the needs of Indonesia’s healthcare system.


4. Digital health transformation: In support of Indonesia’s digital health strategy, Siloam Hospitals will integrate AI into its healthcare management systems, including telemedicine, electronic medical records, and remote patient monitoring. The use of AI will improve patient outcomes, optimize hospital operations, increase capacity and provide patients with personalized, data-driven care, even in remote areas.

5. Supporting the Indonesian government’s healthcare goals: The intended partnership aligns with the Indonesian government’s strategy to enhance healthcare accessibility and quality.

6. Expertise sharing for driving ESG in healthcare: Philips will support Siloam Hospitals in advancing its ESG strategic priorities, including sustainability in the supply chain, environmental stewardship, fostering an equitable workplace, and expanding healthcare access and education.

Quotes from key leaders:

Caroline Riady, Deputy President Director of Siloam Hospitals Group: “This partnership with Philips, Siloam Hospitals and Universitas Pelita Harapan is a significant milestone in our journey to bring advanced healthcare technologies to Indonesia. By investing in AI capability and sharing global expertise, we are helping to build a smarter, more efficient healthcare system that will benefit millions of Indonesians and support the national healthcare agenda.”

Roy Jakobs, Chief Executive Officer of Royal Philips: “At Philips, we believe that informatics and AI will help transform healthcare by optimizing workflows, improving efficiency and increasing capacity – making healthcare more accessible and delivering better care for more people. We are excited to collaborate with Siloam Hospitals and Universitas Pelita Harapan to drive this transformation and fully support the Indonesian government’s vision of improving healthcare through digital innovation.”

Rosan Roeslani, Minister of Investment of the Republic of Indonesia: “The future of healthcare is digital, and AI will play a crucial role in revolutionizing how care is provided. The partnership between Philips and Siloam Hospitals, which allows Indonesia to build local capabilities while tapping into global advancements in AI technology, is an exemplary collaboration to ensure the future economic development and sustainability of Indonesia.”

For further information, please contact:

Mark Groves
Philips External Relations
Tel.: +31 631 639 916
E-mail: [email protected]

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2023 sales of EUR 18.2 billion and employs approximately 68,700 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Attachment


Primary Logo

More from this category

  • Medical Health Aged Care
  • 18/03/2026
  • 18:41
Samsung Bioepis Co., Ltd.

Samsung Bioepis Enters into Partnership Agreement with Sandoz for Up to Five Next-Generation Biosimilar Candidates

The agreement covers up to five assets, including SB36, a biosimilar candidate referencing Entyvio (vedolizumab), for collaboration of development and commercialization in global markets excluding China, Hong Kong, Taiwan, Macau, and Republic of KoreaSamsung Bioepis continues to pave the way for access to life-changing medicines by advancing a biosimilar pipeline across immunology and oncology   INCHEON, Korea--BUSINESS WIRE-- Samsung Bioepis Co., Ltd. announced today that the company has entered into a global license, development and commercialization agreement (DCA) with Sandoz for up to five biosimilar candidates under development by Samsung Bioepis, including SB36, a biosimilar candidate referencing Entyvio1 (vedolizumab). The…

  • Contains:
  • Medical Health Aged Care
  • 18/03/2026
  • 16:49
Palliative Care Australia

Better end-of-life care for older Australians must be the next step in aged care reform

Palliative Care Australia this week brought leaders from aged care, palliative care, health, advocacy, research and policy together in Melbourne for its inauguralPalliative Care…

  • Contains:
  • Indigenous, Medical Health Aged Care
  • 18/03/2026
  • 07:21
Australian and New Zealand Journal of Public Health / Public Health Association of Australia

Emerging Aboriginal leaders call for greater Indigenous control over native foods

As Australia’s native food industry booms, experts say Indigenous people must have a seat at the table Aboriginal leaders and advocates have joined together today to call out commercial companies exploiting native food knowledge without adequate community engagement. They are urging government action to ensure Indigenous people can better lead and control the access and benefits that arise from their traditional foods and knowledge. The new evidence-based commentary, published in the Australian and New Zealand Journal of Public Health, represents the collective view of six leading Aboriginal academics and one non-Indigenous researcher with expertise across bush food, traditional Indigenous medicines,…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.